BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 24709009)

  • 1. Protein mislocalization: mechanisms, functions and clinical applications in cancer.
    Wang X; Li S
    Biochim Biophys Acta; 2014 Aug; 1846(1):13-25. PubMed ID: 24709009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic role of p21 in hepatocarcinogenesis suggests a new treatment strategy.
    Ohkoshi S; Yano M; Matsuda Y
    World J Gastroenterol; 2015 Nov; 21(42):12150-6. PubMed ID: 26576099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia.
    Min YH; Cheong JW; Kim JY; Eom JI; Lee ST; Hahn JS; Ko YW; Lee MH
    Cancer Res; 2004 Aug; 64(15):5225-31. PubMed ID: 15289327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extra-cellular vesicles carry proteome of cancer hallmarks.
    Carvalho AS; Baeta H; Silva BC; Moraes MCS; Bodo C; Beck HC; Rodriguez MS; Saraswat M; Pandey A; Matthiesen R
    Front Biosci (Landmark Ed); 2020 Jan; 25(3):398-436. PubMed ID: 31585894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tale of TALE, PREP1, PBX1, and MEIS1: Interconnections and competition in cancer.
    Blasi F; Bruckmann C; Penkov D; Dardaei L
    Bioessays; 2017 May; 39(5):. PubMed ID: 28322463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy.
    Ray D; Cuneo KC; Rehemtulla A; Lawrence TS; Nyati MK
    Neoplasia; 2015 Sep; 17(9):697-703. PubMed ID: 26476077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in breast cancer metastasis suppressor 1.
    Chen X; Xu Z; Wang Y
    Int J Biol Markers; 2011; 26(1):1-8. PubMed ID: 21279956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siah: a promising anticancer target.
    Wong CS; Möller A
    Cancer Res; 2013 Apr; 73(8):2400-6. PubMed ID: 23455005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of transforming viruses on cellular mutagenesis, genome stability, and cellular transformation.
    Gatza ML; Chandhasin C; Ducu RI; Marriott SJ
    Environ Mol Mutagen; 2005; 45(2-3):304-25. PubMed ID: 15645440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3 proteins as potential oncogenes.
    Tzivion G; Gupta VS; Kaplun L; Balan V
    Semin Cancer Biol; 2006 Jun; 16(3):203-13. PubMed ID: 16725345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple pathways regulated by the tumor suppressor PP2A in transformation.
    Westermarck J; Hahn WC
    Trends Mol Med; 2008 Apr; 14(4):152-60. PubMed ID: 18329957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology.
    Goel RK; Lukong KE
    Cancer Metastasis Rev; 2016 Jun; 35(2):179-99. PubMed ID: 27067725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ER functions of oncogenes and tumor suppressors: Modulators of intracellular Ca(2+) signaling.
    Bittremieux M; Parys JB; Pinton P; Bultynck G
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt B):1364-78. PubMed ID: 26772784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interface between normal and transformed epithelial cells: a road to a novel type of cancer prevention and treatment.
    Fujita Y
    Cancer Sci; 2011 Oct; 102(10):1749-55. PubMed ID: 21692919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX family: Oncogenes or tumor suppressors (Review).
    Otálora-Otálora BA; Henríquez B; López-Kleine L; Rojas A
    Oncol Rep; 2019 Jul; 42(1):3-19. PubMed ID: 31059069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia.
    Mott JL
    Hepatology; 2009 Aug; 50(2):630-7. PubMed ID: 19585622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Id3 modulates cellular localization of bHLH Ptf1-p48 protein.
    Dufresne M; Clerc P; Dieng M; Edir A; Couvelard A; Delisle MB; Fourmy D; Gigoux V
    Int J Cancer; 2011 Jul; 129(2):295-306. PubMed ID: 20830706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Opposing Roles of PIK3R1/p85α and PIK3R2/p85β in Cancer.
    Vallejo-Díaz J; Chagoyen M; Olazabal-Morán M; González-García A; Carrera AC
    Trends Cancer; 2019 Apr; 5(4):233-244. PubMed ID: 30961830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of ubiquitin ligases in cancer.
    Qi J; Ronai ZA
    Drug Resist Updat; 2015 Nov; 23():1-11. PubMed ID: 26690337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.